Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Antiemetics And Antinauseants Market Valued at Present and by 2029?

The market size for antiemetics and antinauseants has seen consistent growth in the past years. It is projected to increase from $8.19 billion in 2024 to $8.48 billion in 2025, with a compound annual growth rate (CAGR) of 3.6%. Factors contributing to this growth during the historic period include historical branding and competitive market conditions, traditional treatment preferences, economic situation, past global health-related events, as well as advancements in medical research.

In the forthcoming years, the market size of antiemetics and antinauseants is expected to witness consistent expansion. The sector is projected to reach “$9.64 billion by 2029, courtesy of a compound annual growth rate (CAGR) of 3.3%. The surge during the forecast period could be credited to research and development efforts, economic determinants, competitive market landscape, industrial trends, evolving disease patterns, and health policy and regulatory changes. Key trends anticipated during the forecast period encompass enhanced concentration on patient experience, modifications in healthcare policies, a consumer inclination for non-invasive therapies, an upward trend in chemotherapy and pregnancy-associated nausea cases, and the rise of targeted treatment approaches.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp

#What Drivers Are Influencing Growth In The Antiemetics And Antinauseants Market?

The market for antiemetics and antinauseants is influenced by the escalating prevalence of cancer. One of the most advised remedies for cancer is chemotherapy, which unfortunately leads to side effects such as chemotherapy-induced nausea and vomiting (CINV). Fortunately, antiemetics have been found to prevent CINV in about 60%-70% of patients. For example, The American Cancer Society, a U.S.-based non-profit organization, estimated in April 2024 that around 609,000 cancer-related deaths occurred and approximately 1.9 million new cancer cases were detected in the country in the year 2022. They projected about 620,000 deaths due to cancer, indicating a slight surge in mortality rates in 2024. This growing occurrence of cancer will boost the need for antiemetics and antinauseants, thereby stimulating market revenue.

The antiemetics and antinauseants market covered in this report is segmented –

1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types

2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types

3) By End Users: Hospital, Medical Center, Clinic, Research Institutes

Subsegments:

1) By Dopamine Antagonists: Metoclopramide, Prochlorperazine, Domperidone

2) By NK1 Receptor Antagonists: Aprepitant, Fosaprepitant, Rolapitant

3) By Antihistamines (H1 Histamine Receptor Antagonists): Dimenhydrinate, Meclizine, Diphenhydramine

4) By Cannabinoids: Dronabinol, Nabilone

5) By Benzodiazepines: Lorazepam, Diazepam

6) By Anticholinergics: Scopolamine, Glycopyrrolate

7) By Steroids: Dexamethasone, Methylprednisolone

8) By 5-HT3 Receptor Antagonists: Ondansetron, Granisetron, Palonosetron

9) By Other Drug Types: Herbal Remedies, Acupressure Devices

What Long-Term Trends Are Likely To Affect The Antiemetics And Antinauseants Market?

Leading corporations in the antiemetic and antinauseant industry are focusing on the design of innovative products such as ready-to-use injectables, with the aim of simplifying the therapy process and boosting patient compliance. These ready-to-use solutions are meant to offer quick relief, thus cutting down on the time and complexity usually entailed by conventional injectable treatments. For example, in July 2024, the US-based specialty pharma company Amneal Pharmaceuticals introduced FOCINVEZ, the inaugural ready-to-use injectable variant of fosaprepitant. This product’s purpose is to combat acute and delayed nausea and vomiting that are side effects of intense cancer chemotherapy. Available in a 150 mg/50 mL vial, this Polysorbate 80-free product does not necessitate reconstitution or dilution, facilitating straightforward application. FOCINVEZ, approved for usage in adults and children aged six months upwards, has been allocated a distinct J-code (J1434) for reimbursement purposes.

Which Companies Play A Key Role In The Development Of The Antiemetics And Antinauseants Market?

Major companies operating in the antiemetics and antinauseants market include Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Cipla Ltd., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Baxter International Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Kyowa Hakko Kirin Pharma Co. Ltd., Daiichi Sankyo Company, Braun GmbH, Eisai Co. Ltd., Sun Pharmaceuticals Industries Ltd., Dr. Reddy’s Laboratories, Hikma Pharmaceuticals plc, IPCA Laboratories Ltd., Eagle Pharmaceuticals Inc., Cadila Pharmaceuticals Ltd., Bristol Laboratories Ltd., Tesaro Inc., SRS Pharmaceuticals Pvt. Ltd., Acacia Pharma Ltd., Algen Healthcare Ltd., Mirabilia Sciences Pvt. Ltd., Helsinn Healthcare SA

https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report

What Are The Key Regional Developments Shaping The Antiemetics And Antinauseants Market?

North America was the largest region in the drugs for antiemetics and antinauseants market in 2024. The Middle East is expected to be the fastest-growing region in the global antiemetics and antinauseants market share. The regions covered in the antiemetics and antinauseants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2441&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model